Zhao Deqing, the former chairman of the company, is certainly aware of the company's major changes.
I immediately contacted the broker again, hoping to chat with Wu Zhou again, at least a little more.
"Mr. Wu said that the market value should be calculated according to the market price. In fact, Mr. Zhao, my suggestion is that you can keep the stocks. After all, Mr. Wu also said that from at least the next ten years, , all profits will be invested in the company's research and development. Think about it, with Mr. Wu who puts so much emphasis on research and development, the stocks in your hands will definitely make a lot of money in the future, and they will at least double in ten years."
Zhao Deqing rolled his eyes when he heard this. He was so eager to sell now because of Wu Zhou's decision.
Although the medical industry focuses on research and development, breakthroughs are possible.
But this does not mean that there will definitely be breakthroughs if we focus on research and development.
Moreover, even if all the profits of the entire company are added up, it will only be over a hundred million a year. However, for the head of a domestic medical device company, the research and development expenses for so many years start in the billions. Why would a layman like Wu Zhou manage the company? The effect of funds can be exerted dozens of times.
In his opinion, Wu Zhou's strategy of focusing on research and development is good. Even an outsider has to say that it is really courageous, but it is nothing more than that. He does not have much hope for the company's future.
In addition, as a former chairman whose position has been wiped out, he holds so many shares and has neither job salary nor dividends, and he has not paid dividends for ten years.
Such a large asset can be cashed out directly, so there is no good use for it.
Moreover, these shares constitute the majority of his net worth. Some time ago, it cost money to pull out a group of people from the original company and start a new business.
So after comprehensive consideration, he decided to sell it immediately.
"Mr. Liu, I don't speak secretly. Please help me talk to Mr. Wu about this matter. After the matter is completed, the extra part will be added to five." Zhao Deqing finally gritted his teeth and said.
After the broker heard Zhao Deqing's words, his breathing froze.
Zhao Deqing could hear the other person on the phone, and then took a deep breath.
"Mr. Zhao, this is a big deal. I really want to help, but I really can't help. You can add it up yourself. This is the price. It seems that Mr. Wu will go back tomorrow. He is very busy. It may not be possible next time. When is it?" Just kidding, if it is the first time to cooperate with Wu Zhou, the broker will most likely agree to Zhao Deqing's plan.
After all, who can refuse such a large sum of money.
But his many experiences of working with Wu Zhou told him that Wu Zhou had a very powerful intelligence network.
Thinking back to the first medical device company, Wu Zhou directly gave him a list of the psychological bottom-line prices of each shareholder before they even started talking.
At the beginning, he thought those bottom-line prices were just a joke, but during the subsequent negotiations, he discovered it.
Almost without exception, in the end, the transaction is done at the bottom line price.
The bottom line price given to Zhao Deqing by Mr. Wu was the original price.
Therefore, as a person who just passes the microphone, there is no room for him to make a profit.
"Okay, that's the price."
After a long silence, Zhao Deqing finally compromised as expected.
After all, Wu Zhou has already obtained the vast majority of the company's shares. As a top tycoon worth hundreds of billions, he has many means, or in other words, a team that can help him pay for the company he acquired.
If he really wants to go against Wu Zhou, he will most likely end up with nothing.
It's better to settle for peace of mind. Having such a large amount of money is enough.
"Mr. Zhao, I have to confirm with you again that you won't change your mind again when we get there."
Of the three medical device companies, the acquisition of Zhao Deqing and Mi Xuexia's medical device company was the most troublesome, but the acquisition amount was also the lowest. In the end, it only cost 3.5 billion.
Originally they negotiated a 50% premium, but in the end due to the couple's various twists and turns, the overall actual premium was only 25%.
This combination actually saved Wu Zhou 700 million.
The three medical device companies in his possession cost Wu Zhou a total of 15.3 billion.
In addition to the 7 billion from Sinovac and the signing fees of some talents, the top researchers who have arrived in March have received project funds.
In the field of biomedicine, nearly 10 billion have been spent.
If we add this up, the numbers are quite encouraging, almost 25 billion.
In January and February, under this special market situation, Wu Zhou's company's total sales revenue profit was about 28.3 billion.
For additional income, about 2,000 mask production lines have been booked, with a payment of 3.6 billion and an estimated profit of about 3 billion.
So total it up.
In the first two months, Wu Zhou Company's total profit was approximately 31.3 billion.
This time, 25 billion was spent, but if you look at the company's financial report, there is still a profit of 6.3 billion on the account.
It was also because the money was enough, and Wu Zhou spent it lavishly.
All the revenue and profits of the medical device company in the next ten years will be spent on the research and development of the company's industrial chain.
This is no joke, of course you have to do your best.
Throughout early March, Wu Zhou devoted almost all of his time to these medical-related companies.
After all, so much money was spent.
The medical device companies he bought were the result of Wu Zhou's careful selection.
It’s not just the potential of its own R&D team.
There is also the production capacity and technical capabilities of the processing plants controlled by the company.
We have the best processing plants in the domestic industry, and the production quality is top-notch even internationally.
Furthermore, one of the few manufacturing companies in China that possesses core technologies and is technologically advanced can directly produce the core component technologies of some medical devices. Although its performance is slightly behind the national first-tier level, it is not far behind.
Now that we have the best OEM quality control factory, of course, the products related to the three medical devices can be transferred as soon as possible.
But there are some things that factories may not be able to produce.
At this time, some engineers are doing targeted design and debugging. The production level of other holdings is average. If they need to be rectified or stopped, they must improve the standards of the products they produce.
, In terms of industrial chain production optimization, Wuzhou Company's original technical department will also be combined to coordinate and cooperate to strive for further improvement in quality control and automated production.
As for the core component technology, since it is currently not as good as the international first-tier, then we should increase research and development and strive to reach the international first-tier, or even surpass their level. At the same time, Wu Zhou will also screen for necessary patents to see if they can Buy it.
Let’s look again to see if the top experts behind these technologies can be poached.
Scientific research requires time, money, people, and direction. After all, the direction is wrong and everything is in vain.
Fortunately, Wu Zhou can satisfy these things except time.
After working continuously for many days, Wu Zhou also felt that his brain was a little tired.
But suddenly Wu Zhou saw a piece of news.
"On March 9, the New York stock market plummeted at the opening, triggering the circuit breaker mechanism, and the composite index fell by more than 7%."
Wu Zhou "."
(End of chapter)
